Neuroimmune-Repair Group, Hospital Nacional de Parapléjicos (HNP), SESCAM, Finca La Peraleda s/n, 45071-Toledo, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Carlos III Health Institute, Av. Monforte de Lemos, 3-5, 28029-Madrid, Spain.
Nanoscale. 2024 Apr 18;16(15):7515-7531. doi: 10.1039/d3nr05351b.
Despite the pharmacological arsenal approved for Multiple Sclerosis (MS), there are treatment-reluctant patients for whom cell therapy appears as the only therapeutic alternative. Myeloid-derived suppressor cells (MDSCs) are immature cells of the innate immunity able to control the immune response and to promote oligodendroglial differentiation in the MS animal model experimental autoimmune encephalomyelitis (EAE). However, when isolated and cultured for cell therapy purposes, MDSCs lose their beneficial immunomodulatory properties. To prevent this important drawback, culture devices need to be designed so that MDSCs maintain a state of immaturity and immunosuppressive function similar to that exerted in the donor organism. With this aim, we select graphene oxide (GO) as a promising candidate as it has been described as a biocompatible nanomaterial with the capacity to biologically modulate different cell types, yet its immunoactive potential has been poorly explored to date. In this work, we have fabricated GO films with two distintive redox and roughness properties and explore their impact in MDSC culture right after isolation. Our results show that MDSCs isolated from immune organs of EAE mice maintain an immature phenotype and highly immunosuppressive activity on T lymphocytes after being cultured on highly-reduced GO films (rGO) compared to those grown on conventional glass coverslips. This immunomodulation effect is depleted when MDSCs are exposed to slightly rougher and more oxidized GO substrates (rGO), in which cells experience a significant reduction in cell size associated with the activation of apoptosis. Taken together, the exposure of MDSCs to GO substrates with different redox state and roughness is presented as a good strategy to control MDSC activity . The versatility of GO nanomaterials in regards to the impact of their physico-chemical properties in immunomodulation opens the door to their selective therapeutic potential for pathologies where MDSCs need to be enhanced (MS) or inhibited (cancer).
尽管有批准用于多发性硬化症(MS)的药理学武器库,但仍有一些对治疗有抵触的患者,他们认为细胞疗法是唯一的治疗选择。髓源性抑制细胞(MDSCs)是先天免疫的未成熟细胞,能够控制免疫反应并在 MS 动物模型实验性自身免疫性脑脊髓炎(EAE)中促进少突胶质细胞分化。然而,当为细胞治疗目的而分离和培养时,MDSCs 会失去其有益的免疫调节特性。为了防止这一重要缺陷,培养设备需要设计成使 MDSCs 保持类似于在供体器官中发挥作用的未成熟和免疫抑制功能的状态。为此,我们选择氧化石墨烯(GO)作为一种很有前途的候选材料,因为它已被描述为一种具有生物调节不同细胞类型能力的生物相容性纳米材料,但迄今为止,其免疫活性潜力尚未得到充分探索。在这项工作中,我们制备了具有两种独特氧化还原和粗糙度特性的 GO 薄膜,并探索了它们对刚分离的 MDSC 培养的影响。我们的结果表明,与在常规玻璃载玻片上生长的细胞相比,从 EAE 小鼠免疫器官中分离的 MDSCs 在高度还原的 GO 薄膜(rGO)上培养后,保持未成熟表型和对 T 淋巴细胞的高度免疫抑制活性。当 MDSCs 暴露于稍微粗糙和更氧化的 GO 底物(rGO)时,这种免疫调节作用会被耗尽,在这些底物中,细胞会经历与细胞凋亡激活相关的细胞大小显著减小。总之,将 MDSCs 暴露于具有不同氧化还原状态和粗糙度的 GO 底物被认为是控制 MDSC 活性的一种很好的策略。GO 纳米材料在其物理化学性质对免疫调节影响方面的多功能性为其在需要增强(MS)或抑制(癌症)MDSCs 的疾病中的选择性治疗潜力开辟了道路。